Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

AngioDynamics Q3 Adjusted EPS $(0.16) Misses $(0.13) Estimate, Sales $75.18M Miss $75.73M Estimate

Author: Benzinga Newsdesk | April 04, 2024 07:02am

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 433.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $75.18 million which missed the analyst consensus estimate of $75.73 million by 0.72 percent. This is a 6.85 percent decrease over sales of $80.71 million the same period last year.

Posted In: ANGO